COM-701 is under clinical development by Compugen and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II drugs for Endometrial Cancer have a 22% phase transition success ...

To induce CD28 co-stimulation, we used anti-CD28 antibodies or natural ligands, B7.1 and B7.2. These natural ligands are recombinant proteins containing the extracellular region of B7.1 or B7.2 fused ...

Objective: The role of immune cells in type 1 diabetes (T1D) is unclear. The aim of this study was to assess the causal effect of different immune cells on T1D using Mendelian randomization (MR).